These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10459345)

  • 1. Deletion 5q31 in patients with stable, melphalan-treated multiple myeloma.
    Amiel A; Fridman K; Elis A; Gaber E; Manor Y; Fejgin M; Lishner M
    Cancer Genet Cytogenet; 1999 Aug; 113(1):45-8. PubMed ID: 10459345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of 5q31 and 7q31 in patients with stable melphalan treated multiple myeloma.
    Amiel A; Yukla M; Yogev S; Manor Y; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):84-7. PubMed ID: 15193449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
    Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
    Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.
    Jonsdottir G; Björkholm M; Turesson I; Hultcrantz M; Diamond B; Porwit A; Landgren O; Kristinsson SY
    Eur J Haematol; 2021 Aug; 107(2):275-282. PubMed ID: 33966293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy-related myelodysplastic syndrome. Two cytogenetically unrelated abnormal clones in a patient with multiple myeloma.
    Abeliovich D; Yehuda O; Ben-Neriah S; Matzner Y
    Cancer Genet Cytogenet; 1993 Oct; 70(2):117-9. PubMed ID: 8242590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma.
    Rödjer S; Swolin B; Weinfeld A; Westin J
    Cancer Genet Cytogenet; 1990 Aug; 48(1):67-73. PubMed ID: 2372790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome.
    Ishii Y; Hsiao HH; Sashida G; Ito Y; Miyazawa K; Kodama A; Ohyashiki JH; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Jun; 167(2):131-7. PubMed ID: 16737912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears.
    Bigoni R; Cuneo A; Milani R; Cavazzini F; Bardi A; Roberti MG; Agostini P; della Porta M; Specchia G; Rigolin GM; Castoldi G
    Haematologica; 2001 Apr; 86(4):375-81. PubMed ID: 11325642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.
    Barlogie B; Tricot G; Haessler J; van Rhee F; Cottler-Fox M; Anaissie E; Waldron J; Pineda-Roman M; Thertulien R; Zangari M; Hollmig K; Mohiuddin A; Alsayed Y; Hoering A; Crowley J; Sawyer J
    Blood; 2008 Jan; 111(1):94-100. PubMed ID: 17895401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia.
    Bram S; Swolin B; Rödjer S; Stockelberg D; Ogärd I; Bäck H
    Cancer Genet Cytogenet; 2003 Apr; 142(2):107-14. PubMed ID: 12699885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplasia during the course of myeloma. Restriction of 17p deletion and p53 overexpression to myeloid cells.
    Soenen V; Preudhomme C; Roumier C; Laï JL; Lepelley P; Facon T; Pagniez D; Fenaux P
    Leukemia; 1998 Feb; 12(2):238-41. PubMed ID: 9519788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New complex t(2;11;17)(p21;q23;q11), a variant form of t(2;11), associated with del(5)(q23q32) in myelodysplastic syndrome-derived acute myeloblastic leukemia.
    Yamamoto K; Nagata K; Morita Y; Inagaki K; Hamaguchi H
    Cancer Genet Cytogenet; 2002 Sep; 137(2):119-23. PubMed ID: 12393282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukaemia-specific chromosome damage detected by comet with fluorescence in situ hybridization (comet-FISH).
    Escobar PA; Smith MT; Vasishta A; Hubbard AE; Zhang L
    Mutagenesis; 2007 Sep; 22(5):321-7. PubMed ID: 17575318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
    MacKinnon RN; Kannourakis G; Wall M; Campbell LJ
    Cancer Genet; 2011 Apr; 204(4):187-94. PubMed ID: 21536236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders.
    Neuman WL; Rubin CM; Rios RB; Larson RA; Le Beau MM; Rowley JD; Vardiman JW; Schwartz JL; Farber RA
    Blood; 1992 Mar; 79(6):1501-10. PubMed ID: 1347709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.